Page 7 - Evaluate Pharma News Today

/PRNewswire/ -- CSL Limited Announces Tender Offer To Acquire Vifor Pharma Ltd - Agreement Announced on the Australian Stock Exchange and SIX Swiss Exchange 14...

/PRNewswire/ -- CSL Limited Announces Tender Offer To Acquire Vifor Pharma Ltd - Agreement Announced on the Australian Stock Exchange and SIX Swiss Exchange 14...

Alvotech is a leading pure play biosimilar platform focused on the development and manufacture of high-quality biosimilar medicines for global markets. Biosimilars are therapeutic equivalents to

The pharmaceutical industry is concentrated in the US and Europe. Check out this pharmaceutical industry overview to learn more.

Jul 20, 2021 4:30pm Analysts with Evaluate Pharma predicted the drug could generate nearly $300 million as a treatment for progressive familial intrahepatic cholestasis by 2026.(Pixabay) With a pair of approvals on both sides of the Atlantic, liver disease-focused biotech Albireo is off and running with its new medicine Bylvay. The oral drug, the first treatment for pruritus in patients with progressive familial intrahepatic cholestasis (PFIC), scored an FDA nod Tuesday and a European appro...

Biopharma companies have responded in an astounding manner to the COVID-19 pandemic through vaccines, therapies, diagnostics, and variant tracking.

Learning from the past to shape the future - Magazine Article - PharmaTimes

Here’s a breakdown of the top pharma companies by revenue in 2019, according to information from research firm GlobalData. The pharmaceutical industry is the cornerstone of development, marketing and commercialization for drug treatments and medications for the patient population.  According to data from Statista, revenue in the pharma sector topped US$1 trillion for the first time in 2014, and has steadily increased since then to reach US$1.25 trillion in 2019. North America serves as the ...

Alongside the race for Covid-19 treatments and vaccines, the industry has maintained momentum 2020’s headlines have been dominated by coronavirus since the first reports of a mysterious virus causing pneumonia in Wuhan, China, in January. The pharmaceuticals sector’s response was huge. While the pharma landscape has been somewhat unusual this year, at least some business has carried on. The need for effective and innovative ways to treat disease is something that even a global pandemic will...